Prolonged Remission in a Patient with Relapsed Follicular Lymphoma after a Single Course of Rituximab

Publisher： Karger

E-ISSN： 2296-5262|29|3|90-92

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.3, 2006-03, pp. : 90-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3662-3671

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rapid-Onset, Prolonged Bone Marrow Failure Following Rituximab Therapy of Follicular Lymphoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 6, 2011-05 ,pp. : 322-324

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 7-14

Karger

Access to resources Recommend Favorite

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-07 ,pp. : 497-502

Karger

Access to resources Recommend Favorite

Rituximab Induced Remission in a Patient with Wegener’s Granulomatosis

By  

Nephron Clin Pract, Vol. 99, Iss. 3, 2005-01 ,pp. : c92-c96

Karger

Access to resources Recommend Favorite